Results 141 to 150 of about 688 (206)

Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product. [PDF]

open access: yesTarget Oncol, 2020
Niederwieser D   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy